What’s the deal with the new COVID-19 pills? Why is Emory University’s license perpetuating inequity?

Merith Basey, Executive Director for UAEM North America, writes about the harmful role that Emory University has played in the licensing of a publicly-funded treatment, molnupiravir. Click on the link below for the full article in STAT News.

Leave a Reply

Your email address will not be published. Required fields are marked *

[mc4wp_form id=”670″]